Maria Faner
Nurse Practitioner · El Paso, TXNPI 1750403218
Payments from drug & device makers
Across 67 payments — averaging $110.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$793
- Amgen$666
- AbbVie$566
- Medtronic$552
- Bayer$468
- plus $3K from 21 others
What the payments were for
- Food & beverage$7,372100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 11 | $1,185 |
| Novo Nordisk | 7 | $793 |
| Amgen(2 entities) | 5 | $666 |
| AbbVie | 5 | $566 |
| Medtronic | 5 | $552 |
| Bayer | 4 | $468 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $374 |
| Boehringer Ingelheim | 4 | $279 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $243 |
| GSK | 2 | $221 |
| Abbott | 2 | $199 |
| Abiomed | 2 | $145 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Mylan Specialty L.p. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Johnson & Johnson | 1 | $125 |
| Shield Therapeutics Inc | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Actelion Pharmaceuticals US, Inc. | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Dexcom, Inc. | 1 | $122 |
| Sanofi | 1 | $107 |
| Vifor Pharma, Inc. | 1 | $103 |
| Neurocrine Biosciences, Inc. | 1 | $100 |
| Intuitive Surgical | 1 | $74 |
| Boston Scientific | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,372 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 40 | $14,660 |
| SsdSilver Sulfadiazine | 55 | $1,208 |
| Metronidazole | 11 | $959 |
| Nystatin | 26 | $799 |
| Mupirocin | 27 | $608 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in El Paso
- Amanda FrenchEl Paso$61K
- Lisa SelbyEl Paso$19K
- Miguel RodriguezEl Paso$17K
- Nanette PettryEl Paso$16K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.